Financials data is unavailable for this security.
View more
Year on year Jiangsu Nanfang Medical Co Ltd had net income fall 906.35% from a loss of 14.65m to a larger loss of 147.42m despite a 10.03% increase in revenues from 545.37m to 600.10m. An increase in the cost of goods sold as a percentage of sales from 87.60% to 94.37% was a component in the falling net income despite rising revenues.
| Gross margin | 5.64% |
|---|---|
| Net profit margin | -28.66% |
| Operating margin | -27.99% |
| Return on assets | -12.31% |
|---|---|
| Return on equity | -31.09% |
| Return on investment | -28.91% |
More ▼
Cash flow in CNYView more
In 2023, cash reserves at Jiangsu Nanfang Medical Co Ltd fell by 58.74m. However, the company earned 15.51m from its operations for a Cash Flow Margin of 2.58%. In addition the company used 16.35m on investing activities and also paid 57.71m in financing cash flows.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 1.58 |
|---|---|
| Tangible book value per share | 1.45 |
More ▼
Balance sheet in CNYView more
| Current ratio | 0.7743 |
|---|---|
| Quick ratio | 0.3748 |
| Total debt/total equity | 1.15 |
|---|---|
| Total debt/total capital | 0.5314 |
More ▼
Growth rates in CNY
Year on year, growth in earnings per share excluding extraordinary items dropped -918.21%.
| Div yield(5 year avg) | 0.41% |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | -- |
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -1,009.18 |
More ▼
